SBC Medical Group (NASDAQ:SBC) Cut to “Buy” at Wall Street Zen

Wall Street Zen lowered shares of SBC Medical Group (NASDAQ:SBC) from a strong-buy rating to a buy rating in a report published on Sunday morning,Wall Street Zen reports.

SBC has been the topic of several other research reports. Weiss Ratings upgraded shares of SBC Medical Group from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Tuesday, September 22nd. BTIG Research reissued a “buy” rating and set a $8.00 price target on shares of SBC Medical Group in a report on Thursday, August 13th. Two research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat, SBC Medical Group presently has a consensus rating of “Moderate Buy” and an average price target of $8.50.

SBC Medical Group Trading Down 3.8%

SBC stock opened at $4.84 on Friday. SBC Medical Group has a 1-year low of $2.78 and a 1-year high of $5.29. The company has a current ratio of 3.31, a quick ratio of 3.27 and a debt-to-equity ratio of 0.09. The business’s 50 day moving average is $3.92 and its 200-day moving average is $3.59. The firm has a market cap of $497.79 million, a P/E ratio of 10.30 and a beta of 0.63.

SBC Medical Group (NASDAQ:SBC) last announced its quarterly earnings results on Thursday, August 13th. The company reported $0.10 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.02). SBC Medical Group had a net margin of 27.99% and a return on equity of 18.47%. The company had revenue of $49.19 million during the quarter, compared to analyst estimates of $45.37 million. Equities analysts anticipate that SBC Medical Group will post 0.44 earnings per share for the current fiscal year.

Institutional Trading of SBC Medical Group

Large investors have recently made changes to their positions in the business. Bank of New York Mellon Corp bought a new position in shares of SBC Medical Group in the first quarter valued at about $43,000. Bank of America Corp DE bought a new stake in SBC Medical Group during the 2nd quarter worth about $35,000. Williams & Novak LLC raised its stake in shares of SBC Medical Group by 31.2% in the second quarter. Williams & Novak LLC now owns 18,686 shares of the company’s stock worth $58,000 after acquiring an additional 4,449 shares during the last quarter. Deutsche Bank AG bought a new position in shares of SBC Medical Group in the second quarter worth about $58,000. Finally, Two Sigma Securities LLC bought a new position in shares of SBC Medical Group in the second quarter worth about $66,000. Institutional investors own 60.82% of the company’s stock.

About SBC Medical Group

SBC Medical Group (NASDAQ: SBC) is a Japan-based medical services and management company focused primarily on the aesthetic medicine sector. Through its affiliated medical corporations and clinic network, the company supports the operation of facilities offering cosmetic surgery, cosmetic dermatology and related elective treatments.

The company provides a range of management and operational services to affiliated clinics, including branding and marketing, staff recruitment and training, purchasing, information technology, administrative support and business consulting.